Cite

HARVARD Citation

    Ruperto, N. et al. (2021). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Lancet. 398 (10315), pp. 1984-1996. [Online]. 
  
Back to record